T-Cell Receptor Optimization with Reinforcement Learning and Mutation Polices for Precision Immunotherapy

Publication Date: 4/16/2023

Event: RECOMB 2023

Reference: pp. 174-191, 2023

Authors: Ziqi Chen, NEC Laboratories America, Inc.The Ohio State University; Martin Renqiang Min, NEC Laboratories America, Inc.; Hongyu Guo, National Research Council Canada; Chao Cheng, Baylor College of Medicine; Trevor Clancy, NEC Oncoimmunity As; Xia Ning, The Ohio State University

Abstract: T cells monitor the health status of cells by identifying foreign peptides displayed on their surface. T-cell receptors (TCRs), which are protein complexes found on the surface of T cells, are able to bind to these peptides. This process is known as TCR recognition and constitutes a key step for immune response. Optimizing TCR sequences for TCR recognition represents a fundamental step towards the development of personalized treatments to trigger immune responses killing cancerous or virus-infected cells. In this paper, we formulated the search for these optimized TCRs as a reinforcement learning (RL) problem and presented a framework TCRPPO with a mutation policy using proximal policy optimization. TCRPPO mutates TCRs into effective ones that can recognize given peptides. TCRPPO leverages a reward function that combines the likelihoods of mutated sequences being valid TCRs measured by a new scoring function based on deep autoencoders, with the probabilities of mutated sequences recognizing peptides from a peptide-TCR interaction predictor. We compared TCRPPO with multiple baseline methods and demonstrated that TCRPPO significantly outperforms all the baseline methods to generate positive binding and valid TCRs. These results demonstrate the potential of TCRPPO for both precision immunotherapy and peptide-recognizing TCR motif discovery.

Publication Link: https://link.springer.com/chapter/10.1007/978-3-031-29119-7_11